Literature DB >> 25043660

Cytology and human papillomavirus testing on cytobrushing samples from patients with head and neck squamous cell carcinoma.

Maria Gabriella Donà1, Massimo Giuliani, Amina Vocaturo, Giuseppe Spriano, Barbara Pichi, Francesca Rollo, Livia Ronchetti, Renato Covello, Edoardo Pescarmona, Maria Benevolo.   

Abstract

BACKGROUND: The increasing incidence of human papillomavirus (HPV)-related head and neck squamous cell carcinoma (HNSCC) highlights the need for simple and effective tools to evaluate head and neck lesions and their HPV status. The main objective of the current study was to investigate the association between abnormal cytology and HPV infection, assessed on cytobrushing samples, and histologically confirmed HNSCC. Second, the authors attempted to investigate whether HPV status on cytobrushing samples reflected that of the tumoral tissue.
METHODS: A total of 164 samples from HNSCC, nonmalignant lesions, or healthy mucosae of the oral cavity and oropharynx were collected by cytobrushing in PreservCyt solution and evaluated by liquid-based cytology and Linear Array HPV genotyping test. All the findings from the cytologic samples were compared with those from the corresponding histologic samples.
RESULTS: Patients with abnormal cytology had a significantly higher risk of having an HNSCC (odds ratio [OR], 9.18; 95% confidence inteval [95% CI], 3.27-26.49). The association was stronger for oral cancer (OR, 10.86; 95% CI, 2.51-51.06) than oropharyngeal cancer (OR, 8.45; 95% CI, 1.62-49.82). HPV positivity in the oropharyngeal cytobrushing was associated with a nearly 5-fold higher risk of having abnormal cytology (OR, 4.57; 95% CI, 1.57-13.57) as well as histologically proven oropharyngeal cancer (OR, 5.09; 95% CI, 1.09-31.61). Comparing the HPV status on cytologic and corresponding histologic samples from patients with HNSCC, we found that 90.4% of the cases were concordant (kappa, 0.796).
CONCLUSIONS: Abnormal brushing cytology is strongly associated with a diagnosis of HNSCC, whereas HPV positivity on cytobrushing samples is only associated with oropharyngeal cancer. HPV testing on cytobrushing samples represents a valid option for the assessment of HPV infection in patients with oropharyngeal cancer.
© 2014 American Cancer Society.

Entities:  

Keywords:  cytology; head and neck; human papillomavirus; squamous cell carcinoma

Mesh:

Year:  2014        PMID: 25043660     DOI: 10.1002/cncr.28909

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Current and future techniques for human papilloma virus (HPV) testing in oropharyngeal squamous cell carcinoma.

Authors:  Ali Qureishi; Thomas Mawby; Lisa Fraser; Ketan A Shah; Henrik Møller; Stuart Winter
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-11       Impact factor: 2.503

Review 2.  Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published data.

Authors:  P Morbini; M Benazzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-08       Impact factor: 2.124

3.  Developing a new diagnostic algorithm for human papilloma virus associated oropharyngeal carcinoma: an investigation of HPV DNA assays.

Authors:  Natasha Cohen; Michael Gupta; Lilian Doerwald-Munoz; Dan Jang; James Edward Massey Young; Stuart Archibald; Bernard Jackson; Jenny Lee; Max Chernesky
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-02-13

4.  Oropharynx HPV status and its relation to HIV infection.

Authors:  Leonora Maciel de Souza Vianna; Fabiana Pirani Carneiro; Rivadavio Amorim; Eliete Neves da Silva Guerra; Florêncio Figueiredo Cavalcanti Neto; Valdenize Tiziani; Andrea Barretto Motoyama; Anamélia Lorenzetti Bocca
Journal:  PeerJ       Date:  2018-03-22       Impact factor: 2.984

Review 5.  Human papillomavirus genome variants and head and neck cancers: a perspective.

Authors:  Jean-Damien Combes; Silvia Franceschi
Journal:  Infect Agent Cancer       Date:  2018-04-10       Impact factor: 2.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.